Healing

Drugmakers Sue Teva Over Insomnia Treatment Patent

Posted on by admin
13
Dec

By Silvia Martelli (December 13, 2021, 6:30 PM GMT) — Drugmakers Neurim and Flynn have sued a generics pharma giant for infringing their patent at the core of melatonin medicines used to treat insomnia.

Neurim Pharmaceuticals (1991) Ltd., which is based in Israel, and Flynn Pharma Ltd. sued generic drugmaker Teva UK Ltd. for bringing its melatonin product to the U.K. market. The product infringes on a patent owned by Neurim, according to the two companies’ Nov. 24 High Court claim. Flynn is the exclusive licensee for the patent under a 2011 agreement with Neurim that was amended in 2020, according to the particulars of claim, which have just been made…

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

admin

Leave a Reply

Your email address will not be published. Required fields are marked *